Skip to main content
. 2019 Mar 29;30(5):e81. doi: 10.3802/jgo.2019.30.e81

Fig. 1. Number of patients included for analysis. One hundred seventeen patients were in the IDS group and 26 in the Add-C group.

Fig. 1

Add-C, additional chemotherapy; IDS, interval debulking surgery; NAC, neoadjuvant chemotherapy; PD, progressive disease; PDS, primary debulking surgery; SD, stable disease.